BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33567773)

  • 1. Plasminogen Receptors and Fibrinolysis.
    Miles LA; Ny L; Wilczynska M; Shen Y; Ny T; Parmer RJ
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview on fibrinolysis: plasminogen activation pathways on fibrin and cell surfaces.
    Anglés-Cano E
    Chem Phys Lipids; 1994 Jan; 67-68():353-62. PubMed ID: 8187235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin-associated plasminogen activation in alpha 2-plasmin inhibitor deficiency.
    Aoki N; Sakata Y; Ichinose A
    Blood; 1983 Nov; 62(5):1118-22. PubMed ID: 6626743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The plasminogen receptor, Plg-R
    Ny L; Parmer RJ; Shen Y; Holmberg S; Baik N; Bäckman A; Broden J; Wilczynska M; Ny T; Miles LA
    Cell Death Dis; 2020 Dec; 11(12):1054. PubMed ID: 33311441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung.
    Hattori N; Sisson TH; Xu Y; Desai TJ; Simon RH
    Am J Physiol; 1999 Sep; 277(3):L573-9. PubMed ID: 10484465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
    Angles-Cano E; Rouy D; Lijnen HR
    Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of plasminogen activation and the variability of the fibrin effector during tissue-type plasminogen activator-mediated fibrinolysis.
    Thorsen S
    Ann N Y Acad Sci; 1992 Dec; 667():52-63. PubMed ID: 1309072
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.
    Sakai M; Watanuki M; Matsuo O
    Biochem Biophys Res Commun; 1989 Jul; 162(2):830-7. PubMed ID: 2527034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the pericellular fibrinolytic system in angiogenesis.
    Fukao H; Ueshima S; Okada K; Matsuo O
    Jpn J Physiol; 1997 Apr; 47(2):161-71. PubMed ID: 9201545
    [No Abstract]   [Full Text] [Related]  

  • 10. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
    Bugge TH; Flick MJ; Danton MJ; Daugherty CC; Romer J; Dano K; Carmeliet P; Collen D; Degen JL
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5899-904. PubMed ID: 8650190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin-specific fibrinolysis.
    Collen D; Lijnen HR
    Ann N Y Acad Sci; 1992 Dec; 667():259-71. PubMed ID: 1285022
    [No Abstract]   [Full Text] [Related]  

  • 14. Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?
    Hervio L; Chapman MJ; Thillet J; Loyau S; Anglés-Cano E
    Blood; 1993 Jul; 82(2):392-7. PubMed ID: 8329699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profibrinolytic effects of metalloproteinases during skin wound healing in the absence of plasminogen.
    Green KA; Almholt K; Ploug M; Rønø B; Castellino FJ; Johnsen M; Bugge TH; Rømer J; Lund LR
    J Invest Dermatol; 2008 Aug; 128(8):2092-101. PubMed ID: 18337830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasminogen activation and regulation of fibrinolysis].
    Madoiwa S
    Nihon Rinsho; 2014 Jul; 72(7):1218-23. PubMed ID: 25163311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of kringles K1-3, K4 and K5 on lysis of fibrin clots caused by the activation of Glu- and Lys-plasminogen by a tissue activator].
    Taran LD; Makogonenko EM
    Ukr Biokhim Zh (1978); 1989; 61(4):31-6. PubMed ID: 2511651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface.
    Fleury V; Loyau S; Lijnen HR; Nieuwenhuizen W; Anglés-Cano E
    Eur J Biochem; 1993 Sep; 216(2):549-56. PubMed ID: 8375393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple binding with identical linkage: a mechanism that explains the effect of lipoprotein(a) on fibrinolysis.
    Hervio L; Durlach V; Girard-Globa A; Anglés-Cano E
    Biochemistry; 1995 Oct; 34(41):13353-8. PubMed ID: 7577920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and interactions in the activation of cell-associated plasminogen.
    Myöhänen H; Vaheri A
    Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.